How much testing is enough—and when is more testing unlikely to improve the decision? RPs, laboratories, assessors and industry representatives will explore risk-based testing strategies, the use of supplier evidence, proportionality and scientific justification. The discussion will examine how to defend necessary testing, identify avoidable duplication and respond when evidence remains incomplete.